Cancer research
In a groundbreaking mission, scientists from the University of California San Diego (UCSD) are conducting research on a potential new cancer treatment in space, aboard the International Space Station. The study, funded by NASA, aims to analyze the effects of the drug rebecsinib on various types of cancer, including ovarian
Cancer research
Researchers at Nagoya University have discovered a potential new therapeutic target for head and neck squamous cell carcinoma (HNSCC) by investigating the function of the long non-coding RNA Taurine upregulated 1 (TUG1). The study, which was published in the Nagoya Journal of Medical Science, found that TUG1 is overexpressed in
Cancer
Researchers have made significant strides in understanding the role of macropinocytosis in cancer development and treatment, opening doors to innovative approaches in personalized medicine. A study published in the Journal of Controlled Release highlights the importance of modulating macropinocytosis in cancer therapy, offering new opportunities for effective and targeted treatments.
Cancer
New research from Anhui Agricultural University, published in International Immunopharmacology, has shed light on the potential of nanovaccines in combating infectious diseases and cancer. The study, led by researchers Khadija Raziq and Ting Xue, with co-author Dongdong Sun, explores the use of nanovaccines in combinatory immune regulation therapies. According to
Cancer
Researchers at University Teknologi MARA in Malaysia have made significant discoveries about the potential of excipients, typically considered inactive additives, to be used as anti-cancer therapeutics at the nanoscale. According to recent literature, excipient nanoparticles can stimulate reactive oxygen species production, trigger apoptosis, and regulate metastasis, making them a promising
Cancer research
A new study published in Radiology has found that CT colonography is a cost-saving and clinically effective method for colorectal cancer screening compared to stool DNA testing. Colorectal cancer is the second leading cause of cancer-related death globally, and routine screening of the colon and rectum can aid in the
Cancer research
A new study published in Nature Chemical Biology reveals that Aspergillus flavus, a mould historically associated with so-called "mummy curses," contains molecules capable of killing leukemia cells. The research team, led by Sherry Gao, professor of chemical and biomolecular engineering at the University of Pennsylvania, isolated and engineered
Cancer research
The CAR T-cell therapy for acute lymphoblastic leukemia market is currently in the growth stage of its lifecycle, driven by the success of pioneering therapies such as Kymriah and the increasing demand for innovative treatments. The market is expected to grow at a significant rate due to advancements in diagnostic
Cancer
New research on stroke rehabilitation has highlighted the potential of machine learning algorithms to personalize and improve the recovery process for stroke survivors. According to a study published in the Journal of Engineering, stroke is a significant global public health challenge, ranking as the second leading cause of death after
Cancer
Researchers at China Medical University Hospital, led by Dr. Der-Yang Cho, in collaboration with Shine-On Biomedical Co., have developed the world's first targeted exosome drug delivery platform, SOB100, aimed at HLA-G. This innovative platform has shown promising efficacy in treating aggressive cancers such as breast cancer and glioblastoma.
Cancer research
A groundbreaking study published in Nature Communications has revealed significant findings on the use of cancer gene therapy in treating acute myeloid leukemia (AML). Researchers at the Fred Hutchinson Cancer Research Center conducted a phase I/II clinical trial, evaluating the safety, persistence, and efficacy of Epstein-Barr virus (EBV)-
Cancer research
A recent study published in the International Journal of Molecular Sciences has highlighted the potential of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in reducing cardiovascular morbidity and mortality in cancer patients. According to the research, patients with active cancer and cancer survivors are at a significantly increased risk of developing cardiovascular
